Pharmaceutical Business review

Transcept Pharma Q2 net loss widens

The company’s loss from operations for the second quarter of 2011 was $2.22m, compared to $2.05m for the same period in 2010.

For the six months ended 30 June 2011, the company reported a net loss of $4.19m, compared to $3.9m for the same period in 2010.

Transcept’s loss from operations was $4.13m for the six months of 2011, compared to $3.89m for the same period in 2010.